Semaglutide is a lab-made copy of a gut hormone that targets a single receptor to reduce appetite, slow digestion, and help regulate blood sugar
FoodNavigators upcoming Global GLP-1 Disruption webinar, airing February 5, 2026 at 3pm GMT/10am EST, will examine how GLP-1 medications are influencing different categories, where disruption is already visible and where expectations may be running ahead of reality
Li D, Liu X, Pi W, Zhang Y, Yu L, Xu C, et al
Pediatr Res 19:459466 Frye RE, Melnyk S, Macfabe DF (2013) Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder
Its soft, balm-to-oil texture melts away dirt without stripping moisture, leaving the skin feeling soft and refreshed
A shortage of Ozempic